View Press Releases
-
Aptamer Group Introduces Novel Biomarker Discovery Service
-
Advancing regenerative medicine: Cellbricks Therapeutics reaches key milestone using Rousselot biomaterials
Rousselot announces promising preclinical results from a study conducted by Cellbricks Therapeutics, a Berlin-based biotech startup and spin-off from the Technical University of Berlin. As a pioneer in 3D-bioprinting, Cellbricks successfully implanted 3D-bioprinted adipose tissue constructs into mice, with no signs of fibrosis or rejection observed after seven weeks.
Aug 27, 2025
-
Qureight’s AI 3D imaging platform to support Calluna Pharma’s Phase 2 AURORA study of CAL101 in Idiopathic Pulmonary Fibrosis (IPF)
• Qureight’s advanced AI 3D imaging platform to be used across clinical trial to evaluate anatomical lung changes in adult patients, including during patient enrolment • CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
Aug 26, 2025
-
Hongene to supply exNA oligonucleotide technology under new licensing deal
-
DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion
Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
Aug 26, 2025
-
Huateng Pharma Expands Cosmetic Ingredients Portfolio with Reliable, Ready-to-Ship Actives
Huateng Pharma offers reliable cosmetic ingredients including Diethylamino Hydroxybenzoyl Hexyl Benzoate, Tetrahydrocurcumin, and Piroctone Olamine.
Aug 26, 2025
-
eClinical Solutions Announces Integrated Data Review Plan (IDRP) Capabilities Within elluminate Platform
Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency
Aug 20, 2025
-
Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia
-
ZeOmega Launches Smart Auth Optimizer to Transform Prior Authorization
-
Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials
MMS, a global has announced that it has been chosen by Friends of Cancer Research to support the development of practical decision frameworks to inform the interpretation of interim overall survival data in oncology clinical trials.
Aug 19, 2025
-
Ambience Healthcare Joins Epic Toolbox, Unlocking Advanced AI Functionality Within Haiku for Epic Customers
-
TetraScience Launches Tetra Workflows to Automate Scientific Data Workflows at Scale
Tetra Workflows enables laboratories to orchestrate and automate data workflows from instruments to lab informatics software at unprecedented scale and reliability. The platform encompasses the entire journey of scientific data, from initial collection and input through storage, analysis, and reporting, ensuring data quality, reliability, consistency, traceability, and efficiency throughout the process.
Aug 11, 2025
-
Transforming Parkinson’s Disease Treatment , Insilico Medicine Announces IND-enabling Completion for AI-empowered Oral NLRP3 Inhibitor ISM8969
Insilico Medicine has completed IND-enabling studies for ISM8969 the oral NLRP3 inhibitor, and plans to submit the Investigational New Drug (IND) application in the fourth quarter of 2025 to begin clinical validation. Based on the potential of ISM8969 against neurodegenerative disorders, as demonstrated in pre-clinical studies, the drug candidate will be evaluated as a novel option for Parkinson’s disease (PD) treatment. Empowered by Insilico Medicine’s Pharma.AI platform, ISM8969 demonstrated favorable PD/PK profiles, as well as dose-dependent efficacy in motor functions in animal models.
Aug 13, 2025
-
ZeOmega and Clearlink Partners Unite to Streamline Delegated Clinical Services
-
Cotiviti Welcomes Veteran Healthcare Technology Growth Leader Robert Kopanic as Chief Revenue Officer
-
Syncell Announces Strategic Co-Marketing Agreement to Advance High-Resolution Spatial Proteomics
Syncell and Thermo Fisher Scientific are working together to bring a fully integrated, high-resolution spatial proteomics workflow to the market.
Aug 13, 2025
-
Grass America Highlights the Zargen Drawer System: Optimized Storage Solutions for Healthcare Settings
KERNERSVILLE, NC — Grass America, a leader in functional hardware for the cabinet industry, highlights the Zargen Drawer System, an innovative storage solution designed specifically to meet the demanding needs of medical environments. Engineered for efficiency, hygiene, and reliability, the Zargen Drawer System empowers healthcare facilities to elevate their storage standards and streamline operations across departments.
Aug 12, 2025
-
Firstsource and Guidehealth Partner to Accelerate AI-Enabled Value-Based Care Innovation for Health Plans
-
Advarra debuts Braid™ to unlock operational intelligence and workflow automation in clinical trials through AI
Powered by the industry’s largest set of digitized protocols and operational data, Braid enables smarter trial design and greater operational efficiency
Aug 11, 2025
-
CapeStart Expands Operations with New Office in Chennai to Support AI Center of Excellence
With goal of delivering reliable AI solutions for life sciences companies, CapeStart continues to build out GenAI expertise, services, and the MadeAi™ platform
Aug 10, 2025